Finally, we revealed a mechanism for treating ALI in which GC-1 inhibits macrophage ROS-mediated inflammasome activation and pyroptosis through the Nrf2-p53-ASC pathway. This evidence concerns the gene TP53 and acute respiratory distress syndrome.